Breakthroughs in Molecular Testing of Lung Cancer: A Pathologist’s and a Patient Advocate’s Perspective
Sunday, September 9
Join us for a discussion on the pathologist’s integral role in the molecular diagnosis of lung cancer, one of the deadliest forms of cancer that strikes more than 230,000 Americans each year, from a leading expert in the field and a patient advocate.
Marc Ladanyi, MD, FCAP, attending pathologist on the Molecular Diagnostics Service in the Department of Pathology at Memorial Sloan-Kettering in New York, will share the latest information on molecular testing in lung cancer and provide an understanding of the pathologist’s vital role in guiding targeted therapies.
Kim Norris, a UCLA Lung SPORE patient advocate and president of the Lung Cancer Foundation of America, will share how these breakthroughs offer hope to patients.
Philip T. Cagle, MD, FCAP, editor of the award-winning publication, Archives of Pathology & Laboratory Medicine, will facilitate the discussion and provide the audience with the opportunity to ask questions from these two thought-provoking speakers.
Don’t miss this session for which you have the opportunity to earn 1.0 CME/CE credits.